Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
2018 · New England Journal of Medicine · 2,701 citations
https://doi.org/10.1056/nejmoa1810858
C
Cara Mathews
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
243
Papers
8.4K
Citations
34
h-index
64
i10-index
Cara Mathews is an academic researcher. The author has contributed to research in topics: Endometrial and Cervical Cancer Treatments & Ovarian cancer diagnosis and treatment & Genetic factors in colorectal cancer. The author has an h-index of 34, co-authored 207 publications.
ORCID: 0000-0001-8461-4568Papers by this author
worksPembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
2023 · New England Journal of Medicine · 626 citations
https://doi.org/10.1056/nejmoa2302312
Efficacy of Maintenance Olaparib for Patients With Newly Diagnosed Advanced Ovarian Cancer With a BRCA Mutation: Subgroup Analysis Findings From the SOLO1 Trial
2020 · Journal of Clinical Oncology · 116 citations
https://doi.org/10.1200/jco.20.00799
HPV16 variant lineage, clinical stage, and survival in women with invasive cervical cancer
2011 · Infectious Agents and Cancer · 38 citations
https://doi.org/10.1186/1750-9378-6-19
Tolerability of maintenance olaparib in newly diagnosed patients with advanced ovarian cancer and a BRCA mutation in the randomized phase III SOLO1 trial
2021 · Gynecologic Oncology · 35 citations
https://doi.org/10.1016/j.ygyno.2021.07.016
Olaparib treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: Phase II LIGHT study primary analysis
2022 · Gynecologic Oncology · 30 citations
https://doi.org/10.1016/j.ygyno.2022.06.017
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat